Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common stock	Additional paidin capital	Accumulated other comprehensive income	Accumulated deficit	Total
Balance at Beginning of period at Dec. 31, 2023	$ 24	$ 339,655	$ 91	$ (320,889)	$ 18,881
Balance at Beginning of period (in shares) at Dec. 31, 2023	24,494,675
Vesting of restricted stock units and exercise of stock options	$ 1	219	0	0	220
Vesting of restricted stock units and exercise of stock options (in shares)	178,233
Issuance of common stock under the employee stock purchase plan	$ 0	164	0	0	164
Issuance of common stock under the employee stock purchase plan (in shares)	27,969
Shares withheld for employee taxes	$ 0	(328)	0	0	(328)
Shares withheld for employee taxes (in shares)	(46,938)
Foreign currency translation adjustment	$ 0	0	6	0	6
Stockbased compensation expense	$ 0	1,102	0	0	1,102
Stockbased compensation expense (in shares)	0
Net loss	$ 0	0	0	(5,661)	(5,661)
Balance at Ending period at Mar. 31, 2024	$ 25	340,812	97	(326,550)	14,384
Balance at Ending period (in shares) at Mar. 31, 2024	24,653,939
Balance at Beginning of period at Dec. 31, 2024	$ 39	387,059	90	(358,730)	28,458
Balance at Beginning of period (in shares) at Dec. 31, 2024	39,395,712
Vesting of restricted stock units and exercise of stock options	$ 1	0	0	0	1
Vesting of restricted stock units and exercise of stock options (in shares)	198,280
Issuance of common stock under the employee stock purchase plan	$ 0	60	0	0	60
Issuance of common stock under the employee stock purchase plan (in shares)	27,318
Shares withheld for employee taxes	$ 0	(177)	0	0	(177)
Shares withheld for employee taxes (in shares)	(66,539)
Foreign currency translation adjustment	$ 0	0	1	0	1
Stockbased compensation expense	$ 0	1,044	0	0	1,044
Stockbased compensation expense (in shares)	0
Net loss	$ 0	0	0	(11,264)	(11,264)
Balance at Ending period at Mar. 31, 2025	$ 40	$ 387,986	$ 91	$ (369,994)	$ 18,123
Balance at Ending period (in shares) at Mar. 31, 2025	39,554,771